2020
DOI: 10.1016/j.jneumeth.2020.108689
|View full text |Cite
|
Sign up to set email alerts
|

A novel intracochlear injection method for rapid drug delivery to vestibular end organs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 44 publications
0
2
0
Order By: Relevance
“…The advantages of this method consist of the local delivery of the substance and direct access to the perilymph of the inner ear. Although this delivery site is not as extensively used in preclinical studies compared to the previously described sites, the local delivery of different substances at this level of the inner ear remains a viable option [33,34].…”
Section: Intracochlearmentioning
confidence: 99%
“…The advantages of this method consist of the local delivery of the substance and direct access to the perilymph of the inner ear. Although this delivery site is not as extensively used in preclinical studies compared to the previously described sites, the local delivery of different substances at this level of the inner ear remains a viable option [33,34].…”
Section: Intracochlearmentioning
confidence: 99%
“…Active, acute, local delivery has been done with micropipettes or syringe pumps to investigate various drug delivery features such as concentration gradients of a delivered drug from base to apex in the cochlea [15][16][17][18], or to deliver gene and stem cell therapies to the inner ear [19]. Commercially available osmotic pumps (Durect Corp, Cupertino, CA) have also been used extensively for more sustained delivery profiles [20][21][22].…”
Section: Micropumps For Inner Ear Drug Deliverymentioning
confidence: 99%